Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: Implications of margin status on long-term oncologic outcome Journal Article


Authors: Mezhir, J. J.; Shia, J.; Riedel, E.; Temple, L. K.; Nash, G. M.; Weiser, M. R.; Paty, P. B.; Wong, W. D.; Guillem, J. G.
Article Title: Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: Implications of margin status on long-term oncologic outcome
Abstract: OBJECTIVE: Extent of distal resection margins in rectal cancer surgery remains controversial. We set out to determine the long-term oncologic impact of resection margins in patients with locally advanced rectal cancer using a comprehensive pathologic whole-mount section analysis. BACKGROUND: It has been demonstrated that there is minimal disease beyond the gross tumor margin after neoadjuvant combined modality therapy (CMT) for rectal cancer. Although this suggests that close resection margins may be used for sphincter preservation, the long-term oncologic impact of this approach is unclear. METHODS: We prospectively enrolled 103 patients with locally advanced rectal cancer after neoadjuvant CMT. Whole-mount pathologic analysis was performed, and clinicopathologic variables were correlated with disease-specific survival (DSS). RESULTS: Sphincter preservation was achieved in 80% of patients, and the median distal margin was 2 cm (0.1 to10 cm). There were 22 patients (21%) with distal margins 1 cm or less and no patient had a positive distal margin. Median radial margin was 1 cm and 4 patients (4%) had a margin of 1 mm or less. Viable distal intramural tumor spread was found in 3 patients (2.7%) and in all cases was limited to 1 cm or less from the gross tumor edge. At a median follow-up of 68 months, 5-year DSS was 86% and 1 patient experienced a local recurrence. Factors predictive of worse DSS included advanced tumor (T) and nodal (N) stage, tumor progression on neoadjuvant CMT, lack of a complete pathologic response, tumor location of 5 cm or less from the anal verge, and neurovascular invasion. The extent of the distal and radial margins of resection was not associated with DSS. CONCLUSIONS: These results suggest that carefully selected patients with locally advanced rectal cancers who undergo neoadjuvant CMT can achieve excellent local control and DSS with a sphincter-sparing rectal resection and a margin distal clearance of 1 cm. © 2012 Lippincott Williams & Wilkins, Inc.
Keywords: adult; treatment outcome; aged; aged, 80 and over; middle aged; cancer surgery; major clinical study; cancer recurrence; fluorouracil; advanced cancer; multimodality cancer therapy; treatment duration; adjuvant therapy; cancer radiotherapy; radiation dose; combined modality therapy; neoadjuvant therapy; cancer staging; follow up; prospective study; prospective studies; tumor localization; multiple cycle treatment; tumor volume; continuous infusion; pathology; cancer invasion; lung metastasis; folinic acid; adjuvant chemotherapy; organ preservation; external beam radiotherapy; rectal neoplasms; rectum cancer; disease specific survival; rectal cancer; rectum; sphincter; total mesorectal excision; distal intramural spread; distal resection margins; whole-mount analysis; neurovascular invasion
Journal Title: Annals of Surgery
Volume: 256
Issue: 2
ISSN: 0003-4932
Publisher: Lippincott Williams & Wilkins  
Date Published: 2012-08-01
Start Page: 274
End Page: 279
Language: English
DOI: 10.1097/SLA.0b013e31825c13d5
PROVIDER: scopus
PUBMED: 22791103
DOI/URL:
Notes: --- - "Export Date: 1 August 2012" - "CODEN: ANSUA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip B Paty
    496 Paty
  2. James John Mezhir
    13 Mezhir
  3. Jose Guillem
    414 Guillem
  4. Jinru Shia
    715 Shia
  5. Martin R Weiser
    532 Weiser
  6. Garrett Nash
    261 Nash
  7. Larissa Temple
    193 Temple
  8. Douglas W Wong
    178 Wong